Global Nanobiotechnology Applications and Markets 2021-2026: Molecular Diagnostic, Therapeutics, & Biopharmaceutical Application

News provided by

Jul 27, 2021, 15:30 ET

DUBLIN, July 27, 2021 /PRNewswire/ -- The "Nanobiotechnology: Applications and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global market for nanobiotechnology should grow from $38.5 billion in 2021 to $68.4 billion by 2026, at a compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026.

The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology formats that will or likely become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments and forecasted growth from 2021 through 2026.

Given the emerging nature of this industry, it is time to analyze the key trends, markets and industry dynamics to provide a useful basis for decision-making.

In many industries, including the biotechnology industry, nanotechnology is emerging as the platform for materials. The unique properties of nanomaterials allow for added value in a variety of applications, from drug encapsulation and release to biological imaging.

At the same time, the pharmaceutical industry is seeking ways to expand patenting and improve pharmacokinetics. In addition, the diagnostics industry is looking for ways to improve the molecular image of new pharmaceutical products. These converging forces result in nanobiotechnology being used in a variety of applications and materials.

Several nanotechnology platforms are already established and providing significant revenues in drug delivery applications, as well as diagnostics, microbicides and R&D tools. Significant nanotechnology drug formats include polymer, liposomal and nanocrystal drugs. Diagnostic and microbicide formats include nanoparticles, quantum dots and dendrimers. Nanopore formats are emerging in third generation DNA sequencing applications.

The purpose of this report is to provide a global, regional and national assessment of the nanobiotechnology application market's potential as well as its existing products, services, future market sizes. This is important because nanobiotechnology markets vary substantially in terms of regional characteristics and depending on the technology in question.

Technology issues and market-driving forces are discussed. Influencing factors, including drug delivery needs, biologic imaging trends and industry structure, are also discussed. The publisher examines nanobiotechnology companies and industry alliances, nanomaterial consumption, end-user industry, and market-driving forces.

The Report Includes:

Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
Estimation of the market size and market forecast for nanobiotechnology applications, and corresponding market share analysis by molecular diagnostic application, therapeutic application, biopharmaceutical application, and geography
Highlights of key market dynamics, issues and trends, gaps and opportunities influencing current and future demand for nanobiotechnology in the global market and its sub-segments
Regional outlook and a country level assessment of nanobiotechnology applications market considering all macroeconomic factors, and Covid-19 impact analysis within the industry
Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
Discussion of major market segments and their respective technologies in the overall global market for nanobiotechnology
Assessment of major stakeholders and analysis of the key competitive landscape based on recent developments and segmental revenues
Profile descriptions of the leading industry players including Ablynx, Arrowhead Pharmaceuticals Inc., Celgene Corp., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Bio-Gate AG, Nanophase Technologies Corp., and Starpharma Holdings Ltd.

Key Topics Covered:

Chapter 1 Introduction

Nanobiotechnology: Unique Fusion of Biotechnology and Nanotechnology
Market Definition
Study Goals and Objectives
Reasons for Doing the Study
Scope of the Report
Methodology
Intended Audience
Geographic Breakdown
What's New in This Updated Report
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Industry Overview

Nanotechnology Value Chain
Bionanomaterials
Nanoparticles
Nanobiotechnology from Laboratory to Market
Nanobiotechnology Techniques
Nanobiotechnology Costs
Nanobiotechnology Applications Status
Life Cycle Status
Nanobiotechnology Growth Driving Forces

Chapter 4 Market Breakdown by Molecular Diagnostic Application

Diagnostic Applications
Detection Application
Nanoarrays
Individual Target Robes
DNA Probe
RNA Probes
Protein Chips
Sparse Cell Detection
Nanotechnology as a Tool in Imaging
Why Nanoparticles are Important for Imaging
Genomics, Proteomics and Cell Biology Imaging
Emerging Applications of Imaging Reagents
Biopolymeric Nanoparticles in Diagnosis, Detection and Imaging

Chapter 5 Market Breakdown by Therapeutic Application

Drug Delivery Applications
Nano-Based Drug Delivery Systems
Fundamentals of Nanotechnology-Based Techniques in Designing of Drugs
Gene Delivery
Cell/Gene Therapy
Reconstructive Surgery
Nanolaser Surgery
Liposomes
Surfaces

Chapter 6 Market Breakdown by Biopharmaceutical Application

Nanopharmaceuticals
Development of Nanopharmaceuticals
Biomolecular Engineering
Tissue Engineering
Nanostructures
Bioprocessing

Chapter 7 North American Market Outlook

Regional Market Overview

Chapter 8 European Market Outlook

Regional Market Overview

Chapter 9 Asia-Pacific Market Outlook

Regional Market Overview

Chapter 10 Latin America, Middle East and Africa Market Outlook

Regional Market Overview

Chapter 11 Company Profiles

Introduction
Ablynx
Arrowhead Pharmaceuticals Inc.
Avadel Pharmaceuticals Plc
Captivate Pharmaceuticals Llc
Celgene Corp.
Elitechgroup
Eyepoint
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
Nanobio Corp.
Nanophase Technologies Corp.
Starpharma Holdings Ltd.
Vectura Group Plc
Nanobiotechnology Startup Companies
Bio-Gate Ag
Cour Pharmaceutical
Iceutica
Keystone Nano
Meda Biotech
Nanocarrier
Nanomedical Diagnostics
Nuvascular Technologies Inc.
Sitka Biopharma
T2 Biosystems
Zylotherapeutics

For more information about this report visit https://www.researchandmarkets.com/r/7wjt38

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets